SE7907316L - Aminosyralosning - Google Patents

Aminosyralosning

Info

Publication number
SE7907316L
SE7907316L SE7907316A SE7907316A SE7907316L SE 7907316 L SE7907316 L SE 7907316L SE 7907316 A SE7907316 A SE 7907316A SE 7907316 A SE7907316 A SE 7907316A SE 7907316 L SE7907316 L SE 7907316L
Authority
SE
Sweden
Prior art keywords
acid
solution
patient
amino acid
cancer
Prior art date
Application number
SE7907316A
Other languages
Unknown language ( )
English (en)
Other versions
SE448679B (sv
Inventor
K Ozeki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE7907316L publication Critical patent/SE7907316L/sv
Publication of SE448679B publication Critical patent/SE448679B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7907316A 1978-09-04 1979-09-03 Infusionslosning for patienter med cancer innehallande essentiella aminosyror men er fri fran metionin SE448679B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Publications (2)

Publication Number Publication Date
SE7907316L true SE7907316L (sv) 1980-03-05
SE448679B SE448679B (sv) 1987-03-16

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7907316A SE448679B (sv) 1978-09-04 1979-09-03 Infusionslosning for patienter med cancer innehallande essentiella aminosyror men er fri fran metionin

Country Status (10)

Country Link
JP (1) JPS5535049A (sv)
AU (1) AU526207B2 (sv)
CA (1) CA1134275A (sv)
CH (1) CH642541A5 (sv)
DE (1) DE2935709C2 (sv)
FR (1) FR2434622A1 (sv)
GB (1) GB2029220B (sv)
IT (1) IT1194844B (sv)
NL (1) NL190266C (sv)
SE (1) SE448679B (sv)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982003552A1 (en) * 1981-04-17 1982-10-28 Hospital Supply Corp American Improved solution for parenteral nutrition
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
DE3329253A1 (de) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
FR2591893B1 (fr) * 1985-12-19 1988-11-10 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
WO1993006834A1 (fr) * 1991-10-07 1993-04-15 Otsuka Pharmaceutical Factory, Inc. Preparation enterique destinee au traitement du cancer
DE4228897A1 (de) * 1992-08-29 1994-03-03 Wella Ag Mittel zur Festigung der Haare auf der Basis von Lignin oder Ligninderivaten sowie Dihydroxypropyllignin
PT668933E (pt) * 1992-11-19 2003-02-28 Anticancer Inc Utilizacao de metioninase como agente anti-tumor em qimioterapia anti-metionina
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
CA2260886A1 (en) * 1996-07-30 1998-02-05 Novartis Nutrition Ag Amino acid composition and use thereof in treating tumor growth and metastasis
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
EP1163904B1 (en) * 2000-06-16 2006-04-19 Rath, Matthias, Dr. med. Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium
DE60028376T2 (de) * 2000-10-09 2007-06-06 Rath, Matthias, Dr. Therapeutische Kombination des Ascorbats mit Lysin und Arginin für Verhinderung und Behandlung des Krebses
US6974833B2 (en) 2001-01-16 2005-12-13 Matthias Rath Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
JPWO2003030890A1 (ja) * 2001-10-05 2005-02-10 哲朗 浅尾 免疫系活性化剤
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
WO2005092097A1 (en) * 2004-03-19 2005-10-06 Pro-Pharmaceuticals, Inc. Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
DK1909600T3 (da) * 2005-07-29 2012-07-30 Tima Foundation Sammensætning til moderering af alkoholmetabolisme og til at reducere risikoen for alkoholforårsagede sygdomme
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
WO2007016953A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing alcohol induced liver cancer risk
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
WO2008119077A1 (en) 2007-03-28 2008-10-02 University Of Southern California Induction of differential stress resistance and uses thereof
WO2009132320A2 (en) 2008-04-24 2009-10-29 University Of Southern California, Usc Stevens Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
JP6090836B2 (ja) * 2011-02-17 2017-03-08 Ｅａファーマ株式会社 化学療法剤の抗腫瘍活性増強剤
JP2016117702A (ja) * 2014-12-22 2016-06-30 武輝 山田 ガン細胞の死滅法
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
EP3668499A1 (en) 2017-08-14 2020-06-24 Axcella Health Inc. Amino acid compositions for the treatment of liver disease
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT297935B (de) * 1968-05-09 1972-04-10 Astra Ab Verfahren zur Herstellung einer Infusionslösung von essentiellen Aminosäuren zur intravenösen Zufuhr bei urämischen Zuständen
SU423304A3 (sv) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2013026C3 (de) * 1970-03-19 1981-01-29 Wagner, Karl-Heinz, Prof. Dr.Med.Habil., 6300 Giessen Mittel zur Behandlung und Verhütung von Leberkrankheiten und muskulärer Insuffizienz
DE2530246A1 (de) * 1975-07-07 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2531204A1 (de) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung

Also Published As

Publication number Publication date
GB2029220B (en) 1983-03-30
AU5036879A (en) 1980-03-13
SE448679B (sv) 1987-03-16
NL190266B (nl) 1993-08-02
IT1194844B (it) 1988-09-28
AU526207B2 (en) 1982-12-23
GB2029220A (en) 1980-03-19
NL190266C (nl) 1994-01-03
JPS5535049A (en) 1980-03-11
CA1134275A (en) 1982-10-26
FR2434622B1 (sv) 1983-04-15
DE2935709C2 (de) 1986-02-06
JPS6154007B2 (sv) 1986-11-20
NL7906620A (nl) 1980-03-06
CH642541A5 (de) 1984-04-30
IT7905216A0 (it) 1979-09-03
FR2434622A1 (fr) 1980-03-28
DE2935709A1 (de) 1980-03-13

Similar Documents

Publication Publication Date Title
SE7907316L (sv) Aminosyralosning
JPS56110617A (en) Nutrient composition for young child
KR950703987A (ko) G-csf의 안정한 동결건조된 약제학적 제제(stable lyophilized pharma ceutical preparations g-csf)
FI870169A (fi) Stabiliserat tokoferol i fri-flytande partikelform
GB1399888A (en) Injectable amino acid composition
KR830002327A (ko) 약학적 제제
DE58909049D1 (de) Grössenverstellbarer Skischuh.
SE8000435L (sv) N-bensylimidazoler med selektivt inhiberande verkan pa tromboxansyntetasenzymet jemte farmaceutiska beredningar innehallande sadana n-bensylimidazoler och sett for deras framstellning
KR850002277A (ko) 동결건조 b형 간염 왁진조성물 및 그 제조방법
JPS54147916A (en) Preparation of urokinase injection
NL157598B (nl) Werkwijze voor de bereiding van optische bleekmiddelen, afgeleid van 4,4'-bis-(2",4"-diamino-s-triazinyl(6")-amino)-stilbeen-2,2'-disulfonzuur, werkwijze voor het optisch bleken, voorwerpen verkregen onder toepassing van deze werkwijze, alsmede werkwijze voor de bereiding van geconcentreerde vloeibare preparaten.
MX9300759A (es) Compuestos y productos de reaccion de amadori, procedimiento para su fabricacion y su uso.
SE8803935L (sv) Laekemedelskomposition
WO1986002555A3 (fr) Medicament contenant des solutions d'acides amines pour le traitement de maladies cancereuses et son procede de preparation
AR009425A1 (es) Uso de creatina en la preparacion de un farmaco para el tratamiento de insuficiencias cardiacas y/o respiratorias
EP0563383A4 (en) (ganoderma lucidium) iy009 which produces proteoglycan (g009) having effect of enhancing antitumor immunity
DK30581A (da) Fremgangsmaade til fremstilling af 5-aminotetrazolderivater af retinsyrer
GB1477624A (en) Amino acid parenteral solution containing reducing sugar
GB1189935A (en) Dried Stable Anti-Tumour Preparations and a process for preparing the same
AU1509097A (en) Proteoglycan (G 009) effective in enhancing antitumor immunity
NO942323L (no) Soyaprotein eller hydrolysater i farmasöytiske preparater for beskyttelse av bioaktive peptider mot enzymatisk inaktivering
KUŽELA et al. Formation, size, and solubility in chloroform/methanol of products of protein synthesis in isolated mitochondria of rat liver and Zajdela hepatoma
KR920003960A (ko) 안정화된 드링크류의 제조방법
GB944428A (en) Cobalamin derivatives
KR870008581A (ko) 안정하고 주사가능한 1,4-디히드록시-5,8-비스 [2-(2-히드록시에틸아미노)에틸아미노]안트라퀴논, 디히드로클로라이드의 약학적 배합제제

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7907316-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7907316-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7907316-9

Format of ref document f/p: F